Clinical Trial

Combining Dexmedetomidine Infusion and Paragastric Autonomic Neural Block to Enhance Postoperative Recovery in Patients Undergoing Laparoscopic Sleeve Gastrectomy

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated June 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if combining Dexmedetomidine infusion and paragastric autonomic neural block will enhance the postoperative recovery of patients undergoing laparoscopic sleeve gastrectomy. The main questions it aims to answer are: Will combining the two techniques (Dexmedetomidine infusion and paragastric autonomic neural block) improve the quality of recovery? Will opioid consumption postoperatively decrease after combining those two techniques? Will the patients be able to start mobilizing sooner after surgery? Will the patient encounter less incidence of nausea and vomiting? Researchers will asses the quality of the patients' recovery by reviewing the Quality of recovery 40 (QoR 40) questionnaire filled by the patients, assessing hemodynamic parameters intra- and postoperatively, recording the opioids consumed by the patients in the postoperative period, recording the time to first mobilization of the patient, and recording the incidence of nausea and vomiting.
Trial Details
NCT Number NCT06970678
Lead Sponsor Alexandria University
Conditions Laparoscopic Sleeve Gastrectomy (LSG)
Enrollment 46 participants
Start Date 2025-04-04
Primary Completion 2025-06-06 (estimated)
Study Completion 2025-06-18 (estimated)
Updated on ClinicalTrials.gov 2025-05-14